Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000475908 | SCV000541881 | likely benign | Neuroblastoma, susceptibility to, 3 | 2024-01-24 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV002257413 | SCV002528454 | likely benign | Hereditary cancer-predisposing syndrome | 2021-09-13 | criteria provided, single submitter | curation | |
Gene |
RCV002266923 | SCV002549190 | likely benign | not provided | 2023-07-09 | criteria provided, single submitter | clinical testing | See Variant Classification Assertion Criteria. |
Ce |
RCV002266923 | SCV004144025 | benign | not provided | 2022-09-01 | criteria provided, single submitter | clinical testing | ALK: BS1, BS2 |
Revvity Omics, |
RCV002266923 | SCV004238563 | uncertain significance | not provided | 2022-04-01 | criteria provided, single submitter | clinical testing | |
ITMI | RCV000119971 | SCV000084101 | not provided | not specified | 2013-09-19 | no assertion provided | reference population |